Serum NT-pro CNP levels in epileptic seizure, psychogenic non-epileptic seizure, and healthy subjects
Özet
Purpose: Epileptic seizure is the result of uncontrollable neural excitation in the brain. The C-type natriuretic peptide is a member of natriuretic peptide hormone family and is synthesized by brain and blood vessels in CNS. NT-pro CNP is an amino-terminal fragment of C-type natriuretic peptide and is more stable compared to its predecessor. In this study, we aimed to evaluate the role of NT-pro CNP in psychogenic non-epileptic seizures, epileptic seizures, and normal subjects. Methods: Thirty-three patients with epilepsy and 43 patients with psychogenic non-epileptic seizures were enrolled in this study. The control group consisted of 28 healthy subjects. Post-ictal serum levels of NT-pro CNP were acquired from all participants. Statistically significant differences between patient groups and controls regarding serum levels of NT-pro CNP were sought. Results: NT-pro CNP levels were significantly lower in the epilepsy group than the psychogenic non-epileptic seizure group and control group with no significant difference between the psychogenic non-epileptic seizure and control group (p < 0.05). Conclusion: Post-ictal serum NT-pro CNP levels were lower in epileptic seizures compared to psychogenic non-epileptic seizures as well as healthy controls. We think that such a difference is associated with C-type natriuretic peptide-related neural mechanisms such as altered microcirculation, increased brain-blood barrier permeability, and synaptic stabilization. © 2018, Springer-Verlag Italia S.r.l., part of Springer Nature.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Ceylan, Mustafa | |
| dc.contributor.author | Yalcin, Ahmet | |
| dc.contributor.author | Bayraktutan, Omer Faruk | |
| dc.contributor.author | Laloglu, Esra | |
| dc.date.accessioned | 2026-10-18T20:29:16.393271139Z | |
| dc.date.available | 2026-10-18T20:29:16.393271139Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Purpose: Epileptic seizure is the result of uncontrollable neural excitation in the brain. The C-type natriuretic peptide is a member of natriuretic peptide hormone family and is synthesized by brain and blood vessels in CNS. NT-pro CNP is an amino-terminal fragment of C-type natriuretic peptide and is more stable compared to its predecessor. In this study, we aimed to evaluate the role of NT-pro CNP in psychogenic non-epileptic seizures, epileptic seizures, and normal subjects. Methods: Thirty-three patients with epilepsy and 43 patients with psychogenic non-epileptic seizures were enrolled in this study. The control group consisted of 28 healthy subjects. Post-ictal serum levels of NT-pro CNP were acquired from all participants. Statistically significant differences between patient groups and controls regarding serum levels of NT-pro CNP were sought. Results: NT-pro CNP levels were significantly lower in the epilepsy group than the psychogenic non-epileptic seizure group and control group with no significant difference between the psychogenic non-epileptic seizure and control group (p < 0.05). Conclusion: Post-ictal serum NT-pro CNP levels were lower in epileptic seizures compared to psychogenic non-epileptic seizures as well as healthy controls. We think that such a difference is associated with C-type natriuretic peptide-related neural mechanisms such as altered microcirculation, increased brain-blood barrier permeability, and synaptic stabilization. © 2018, Springer-Verlag Italia S.r.l., part of Springer Nature. | |
| dc.identifier.doi | 10.1007/s10072-018-3562-4 | |
| dc.identifier.eissn | 1590-3478 | |
| dc.identifier.endpage | 2139 | |
| dc.identifier.issn | 1590-1874 | |
| dc.identifier.issue | 12 | |
| dc.identifier.pmid | 30232670 | |
| dc.identifier.scopus | 2-s2.0-85053537254 | |
| dc.identifier.startpage | 2135 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14463 | |
| dc.identifier.volume | 39 | |
| dc.identifier.wos | WOS:000452518300015 | |
| dc.language.iso | en | |
| dc.publisher | Springer-Verlag Italia s.r.l. | |
| dc.relation.ispartof | Neurological Sciences | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Biomarker | |
| dc.subject | Epilepsy | |
| dc.subject | NT-pro CNP | |
| dc.subject | Psychogenic non-epileptic seizure | |
| dc.subject | Adolescent | |
| dc.subject | Adult | |
| dc.subject | Electroencephalography | |
| dc.subject | Female | |
| dc.subject | Healthy Volunteers | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Middle Aged | |
| dc.subject | Natriuretic Peptide, C-Type | |
| dc.subject | Psychophysiologic Disorders | |
| dc.subject | Seizures | |
| dc.subject | Statistics, Nonparametric | |
| dc.subject | Video Recording | |
| dc.subject | Young Adult | |
| dc.subject | biological marker | |
| dc.subject | natriuretic peptide type C | |
| dc.subject | amino terminal sequence | |
| dc.subject | Article | |
| dc.subject | blood brain barrier | |
| dc.subject | brain microcirculation | |
| dc.subject | clinical evaluation | |
| dc.subject | controlled study | |
| dc.subject | excitation | |
| dc.subject | human | |
| dc.subject | major clinical study | |
| dc.subject | neurophysiology | |
| dc.title | Serum NT-pro CNP levels in epileptic seizure, psychogenic non-epileptic seizure, and healthy subjects | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 7 | |
| rdl.citation.wos | 7 | |
| rdl.department | Faculty of Medicine, Department of Radiology, Erzincan University, Erzincan, Turkey. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
